Prior CTCL therapies
| Type and no. of treatments . | No. of patients . | |
|---|---|---|
| Early stage . | Advanced stage . | |
| Systemic and skin-directed | ||
| 0 | 0 | 0 |
| 1 | 0 | 0 |
| 2 | 8 | 2 |
| 3 | 6 | 5 |
| 4 or more | 11 | 15 |
| Systemic only | ||
| 0 | 13 | 0 |
| 1 | 5 | 6 |
| 2 | 3 | 3 |
| 3 | 2 | 8 |
| 4 or more | 2 | 5 |
| Type and no. of treatments . | No. of patients . | |
|---|---|---|
| Early stage . | Advanced stage . | |
| Systemic and skin-directed | ||
| 0 | 0 | 0 |
| 1 | 0 | 0 |
| 2 | 8 | 2 |
| 3 | 6 | 5 |
| 4 or more | 11 | 15 |
| Systemic only | ||
| 0 | 13 | 0 |
| 1 | 5 | 6 |
| 2 | 3 | 3 |
| 3 | 2 | 8 |
| 4 or more | 2 | 5 |
Early-stage patients (n = 25) were eligible if they had failed 2 or more prior therapies. Advanced-stage patients (n = 22) were eligible if they had failed one or more prior systemic therapies.